Can Semaglutide Make You Anxious or Affect Your Mood?

Does the prescribing data actually link semaglutide to anxiety?

The short answer is: not in the way it links it to nausea or fatigue. The NHS semaglutide medicine page lists gastrointestinal symptoms — nausea, diarrhoea, constipation, indigestion — as the most commonly reported side effects. Anxiety does not appear in that primary list. The STEP 1 trial, the pivotal 68-week study that supported Wegovy's weight-management licence, similarly showed no significant signal for anxiety as a direct drug effect.

Where it gets more nuanced is in post-marketing surveillance. Since Wegovy became widely used, some patients have reported episodes of heightened anxiety, low mood, and in rarer cases more serious psychological symptoms. Regulators in several countries have reviewed these reports; the MHRA continues to monitor GLP-1 medicines and updates safety guidance when evidence warrants it. If you notice a change in your mental wellbeing after starting semaglutide, that is worth raising with your prescriber, and worth reporting via the Yellow Card scheme so that the picture becomes clearer for everyone.

It is also worth knowing that the question of how semaglutide affects body physiology extends well beyond the gut, which is why researchers are actively studying its neurological effects.

Could the anxiety be coming from something other than the medicine itself?

Quite possibly. This is one of the questions our prescribers hear regularly, and unpicking the cause matters.

The most common culprits that mimic medication-induced anxiety during semaglutide treatment are indirect. Eating significantly less than usual can leave the body running low on calories, and that physiological stress (shakiness, light-headedness, a racing heart) can feel very much like anxiety even when blood glucose is technically within range. Nausea itself is distressing, and persistent nausea in the early weeks of treatment creates its own psychological strain.

There is also the context of starting a new medical treatment for weight management, which many people approach with a mixture of hope and worry. That emotional background can amplify physical sensations. Some people going through rapid weight changes also notice a shift in how they relate to food, which can surface feelings they had not expected. If you have a history of disordered eating or anxiety, it is important to discuss this fully during your clinical assessment before starting treatment. You can read more about the broader landscape of semaglutide for weight management and what to expect.

Staying well hydrated, maintaining adequate protein intake, and not skipping meals entirely are practical steps that can reduce these indirect effects. Your prescriber is the right person to advise on whether any adjustment is appropriate for you.

What does the science say about GLP-1 receptors and the brain?

GLP-1 receptors are not confined to the gut. They are found in regions of the brain involved in reward, appetite regulation, and stress responses. This is part of why semaglutide reduces appetite so effectively, it acts centrally as well as peripherally. It also means the medicine has the biological machinery to influence mood and emotional processing, even if the clinical evidence has not yet established a clear causal link to anxiety in most patients.

Research in this area is genuinely active. Some studies suggest GLP-1 agonists may have a broadly positive effect on mood and motivation in people with obesity. Others point to individual variation, the same receptor activity that calms appetite in one person may tip into edginess or emotional blunting in another. This is an emerging area, and if you are wondering how semaglutide is actually produced, understanding the manufacturing process helps explain why formulation and quality can vary between products. The honest position is that we do not yet have definitive answers about the long-term psychological effects at a population level.

If you are curious about whether Wegovy is right for your specific situation, exploring the Wegovy treatment page gives a grounded overview of how it works and what to weigh up. For a broader look at weight-loss treatment options, that page compares the approaches currently available through a regulated UK service.

When should you actually be concerned, and what should you do?

Feeling slightly on edge in the first fortnight of treatment, especially alongside nausea, is not unusual. If that settles as your body adjusts and you feel otherwise well, it is often a manageable early effect rather than a reason to stop.

Seek prompt medical advice (the same day if possible) if you experience severe anxiety, panic attacks, significant low mood, thoughts of self-harm, or any mood change that feels out of character and persistent. These are not situations to manage alone. If you are already under the care of a mental health professional, let them know you have started a new medicine.

For context on how semaglutide treatment is priced and structured as a private service, the Wegovy cost page sets out what is included in a full treatment pathway. Understanding the structure of care matters, because access to a responsive prescriber when symptoms arise is part of what safe treatment looks like. Patients who want to understand more about the specific branded version used in some UK services may find the Dr Reddy semaglutide page a useful reference. Our FAQs also cover some of the most common questions patients bring to their first consultation.

If something feels off during your treatment, reach out. Our support team is available seven days a week, and your prescriber can review your case without you needing to wait for a scheduled appointment.